Voyager Therapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.55 | $-0.40 | +27.3% | Beat |
| Q12026 FY2026 | $-0.54 | $-0.47 | +13.0% | Beat |
| Q42025 FY2025 | $-0.54 | $-0.46 | +14.8% | Beat |
Back to VYGR overview · VYGR holders · VYGR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.